Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Biol Pharm Bull ; 35(9): 1432-9, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22975492

RESUMO

Indoloquinoline alkaloids represent an important class of antimalarial, antibacterial and antiviral compounds. Indolo[2,3-b]quinolines are a family of DNA intercalators and inhibitors of topoisomerase II, synthetic analogs of neocryptolepine, an alkaloid traditionally used in African folk medicine. These cytotoxic substances are promising anticancer agents. Active representatives of indolo[2,3-b]quinolines affect model and natural membranes. The distinct structure and hydrophobicity of the compounds leads to marked differences in the disturbing effects on membrane organization and function. Our results also indicated a strong relationship between the presence of the chain and the Poct of the molecule as well as the capacity for incorporation into carboxyfluorescein-trapped liposomes in the 0.02-0.06 mM range. Moreover, a correlation between binding to neutral dimyristoylphosphatidylcholine (DMPC) or negative charged dimyristoylphosphatidylcholine:dimyristoylphosphatidylglycerol (DMPC:DMPG, 9:1 w/w) liposomes, as well as to erythrocyte ghosts and pKa, was also found. All the compounds cause hemolysis in isotonic conditions with concentration causing 50% hemolysis (HC50) in the 0.12-0.88 mM range. The concentration-dependent inhibitory effect of the tested agents on erythrocyte ghosts' acetylcholinesterase activity was also studied.


Assuntos
Alcaloides/farmacologia , Antineoplásicos Fitogênicos/farmacologia , Membrana Celular/efeitos dos fármacos , Cryptolepis/química , Eritrócitos/efeitos dos fármacos , Hemólise/efeitos dos fármacos , Extratos Vegetais/farmacologia , Quinolinas/farmacologia , Acetilcolinesterase/metabolismo , Alcaloides/química , Animais , Antineoplásicos Fitogênicos/química , Membrana Celular/metabolismo , Dimiristoilfosfatidilcolina/química , Relação Dose-Resposta a Droga , Eritrócitos/metabolismo , Interações Hidrofóbicas e Hidrofílicas , Substâncias Intercalantes/química , Substâncias Intercalantes/farmacologia , Lipossomos , Medicinas Tradicionais Africanas , Fosfatidilgliceróis/química , Extratos Vegetais/química , Quinolinas/química , Ovinos , Relação Estrutura-Atividade , Inibidores da Topoisomerase II/química , Inibidores da Topoisomerase II/farmacologia
2.
Drug Deliv ; 15(1): 49-56, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18197524

RESUMO

The cytotoxic and antitumor activity of DIMIQ (5,11-dimethyl-5H-indolo[2,3-b]quinoline), synthetic analog of neocryptolepine, makes this compound a potential antitumor agent. An attempt to obtain liposomal form of DIMIQ.HCl was undertaken in the present study. Standard experimental conditions were chosen and information on the physicochemical parameters of the liposome dispersion containing studied indoloquinoline agent was collected. The effective and efficient encapsulation of DIMIQ.HCl (66.6%) in conventional liposomes (FAT-MLV, DMPC:DMPG 7:3 w/w at pH 7.0), uniformity of the size of liposomal vesicles, and high stability at pH 6.5 were demonstrated. Hemolysis of sheep erythrocytes induced by free form of DIMIQ.HCl was dramatically decreased after addition of liposome-entrapped DIMIQ.HCl. Treatment of hepatoma Morris 5123 cells for 24 hr with different concentrations of both free and its liposomal formulation of DIMIQ.HCl resulted in significant changes in cell morphology accompanied by reduction of cell viability.


Assuntos
Antineoplásicos/farmacologia , Carbolinas/farmacologia , Glicerofosfolipídeos/química , Lipossomos , Neoplasias Hepáticas Experimentais/tratamento farmacológico , 1,2-Dipalmitoilfosfatidilcolina/química , Animais , Antineoplásicos/química , Antineoplásicos/uso terapêutico , Antineoplásicos/toxicidade , Carbolinas/química , Carbolinas/uso terapêutico , Carbolinas/toxicidade , Forma Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Química Farmacêutica , Dimiristoilfosfatidilcolina/química , Relação Dose-Resposta a Droga , Composição de Medicamentos , Hemólise/efeitos dos fármacos , Concentração de Íons de Hidrogênio , Neoplasias Hepáticas Experimentais/patologia , Tamanho da Partícula , Fosfatidilgliceróis/química , Ratos , Ratos Endogâmicos BUF , Ovinos , Células Tumorais Cultivadas
3.
Zootaxa ; 4363(1): 79-100, 2017 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-29245410

RESUMO

We examined microscope slides from Horning and Iharos tardigrade collections from Museum of New Zealand Te Papa Tongarewa in Wellington and Hungarian Natural History Museum in Budapest with species of the Macrobiotus hufelandi group. Based on this material we describe one new species, Macrobiotus horningi sp. nov., and re-describe two others, M. maculatus comb. nov. Iharos, 1973 and M. rawsoni Horning et al., 1978. With the oral cavity armature of the patagonicus type and chorion of the hufelandi type, Macrobiotus horningi sp. nov. is most similar to: M. personatus Biserov, 1990, M. sandrae Bertolani & Rebecchi, 1993, M. serratus Bertolani et al., 1996, M. sottilei Pilato et al., 2012, M. terminalis Bertolani & Rebecchi, 1993 and M. vladimiri Bertolani et al., 2011, but it differs from them in morphological and morphometric traits. With eggs of the maculatus type, M. maculatus comb. nov. is most similar to: M. biserovi Bertolani et al., 1996, M. denticulatus Dastych, 2002, M. macrocalix Bertolani & Rebecchi, 1993 and M. ramoli Dastych, 2005, but differs from them in morphological and morphometric characters.


Assuntos
Tardígrados , Animais , Museus , Nova Zelândia , Óvulo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA